Who Owns SCPH?

SCPHARMACEUTICALS INC — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

88

Total Inst. Value

$96.0M

% of Float Held

QoQ Holder Change

+26

Institutional data as of Q1 2025

New Positions

14

Closed Positions

9

Increased

32

Decreased

26

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ORBIMED ADVISORS LLC$15.9M6,059,528
2Rubric Capital Management LP$12.6M4,775,000
3AIGH Capital Management LLC$10.8M4,096,367
4KING LUTHER CAPITAL MANAGEMENT CORP$8.2M3,121,170
5BlackRock, Inc.$6.2M2,356,812
6VANGUARD GROUP INC$5.2M1,992,760
7MORGAN STANLEY$5.0M1,886,141
8RICE HALL JAMES & ASSOCIATES, LLC$3.7M1,398,057
95AM Venture Management, LLC$3.2M1,200,647
10KINGDON CAPITAL MANAGEMENT, L.L.C.$2.6M1,000,000

Biggest Buyers & Sellers This Quarter

Frequently Asked Questions

How many institutional investors hold SCPH?

As of Q1 2025, 88 institutional investors report holding SCPH (SCPHARMACEUTICALS INC) in their 13F filings.

Which hedge fund owns the most SCPH?

The largest institutional holder of SCPH is ORBIMED ADVISORS LLC with $15.9M in shares.

Are institutions buying or selling SCPH?

This quarter, 14 institutions opened new positions in SCPH and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.